The DOI matches its Crossref record; 152 of the 152 references it cites were found in a registry or an index.
Apolipoprotein B and apolipoprotein A‐I: risk indicators of coronary heart disease and targets for lipid‐modifying therapy
Abstract
: Although LDL cholesterol (LDL‐C) is associated with an increased risk of coronary heart disease, other lipoproteins and their constituents, apolipoproteins, may play an important role in atherosclerosis. Elevated levels of apolipoprotein (apo) B, a constituent of atherogenic lipoproteins, and reduced levels of apo A‐I, a component of anti‐atherogenic HDL, are associated with increased cardiac events. Apo B, apo A‐I and the apo B/apo A‐I ratio have been reported as better predictors of cardiovascular events than LDL‐C and they even retain their predictive power in patients receiving lipid‐modifying therapy. Measurement of these apolipoproteins could improve cardiovascular risk prediction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project
Conroy, R. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00114-3 · Cited by 5,290
De Backer, G. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00347-6 · Cited by 2,251
Brown, G., Albers, J. J., Fisher, L. D., Schaefer, S. M., Lin, J.-T., Kaplan, C., Zhao, X.-Q., Bisson, B. D., Fitzpatrick, V. F., & Dodge, H. T. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011083231901 · Cited by 2,159
Serum Cholesterol, Lipoproteins, and the Risk of Coronary Heart Disease: The Framingham Study
KANNEL, W. B., CASTELLI, W. P., GORDON, T., & MCNAMARA, P. M. (1971) · Annals of Internal Medicine · doi:10.7326/0003-4819-74-1-1 · Cited by 2,057
Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction
Austin, M. A. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410130125037 · Cited by 1,780
Incidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels: The Framingham Study
Castelli, W. P. (1986) · JAMA · doi:10.1001/jama.1986.03380200073024 · Cited by 1,611
Jones, P. H., Davidson, M. H., Stein, E. A., Bays, H. E., McKenney, J. M., Miller, E., Cain, V. A., & Blasetto, J. W. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00530-7 · Cited by 1,398
Walldius, G., Jungner, I., Holme, I., Aastveit, A. H., Kolar, W., & Steiner, E. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07098-2 · Cited by 1,229
Self-citationCurrent Perspectives on Statins
Maron, D. J., Fazio, S., & Linton, M. F. (2000) · Circulation · doi:10.1161/01.cir.101.2.207 · Cited by 1,213
Lamarche, B., Tchernof, A., Moorjani, S., Cantin, B., Dagenais, G. R., Lupien, P. J., & Despre´s, J.-P. (1997) · Circulation · doi:10.1161/01.cir.95.1.69 · Cited by 1,077
Hypertriglyceridemia as a cardiovascular risk factor
Austin, M. A., Hokanson, J. E., & Edwards, K. L. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00031-9 · Cited by 1,066
Jeppesen, J. Ø., Hein, H. O., Suadicani, P., & Gyntelberg, F. (1998) · Circulation · doi:10.1161/01.cir.97.11.1029 · Cited by 676
Early incorporation of cell-derived cholesterol into pre-.beta.-migrating high-density lipoprotein
Castro, G. R., & Fielding, C. J. (1988) · Biochemistry · doi:10.1021/bi00401a005 · Cited by 642
Sniderman, A., Shapiro, S., Marpole, D., Skinner, B., Teng, B., & Kwiterovich, P. O. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.1.604 · Cited by 633
Pedersen, T. R., Olsson, A. G., Færgeman, O., Kjekshus, J., Wedel, H., Berg, K., Wilhelmsen, L., Haghfelt, T., Thorgeirsson, G., Pyörälä, K., et al. (1998) · Circulation · doi:10.1161/01.cir.97.15.1453 · Cited by 621
Lipoprotein (a). Heterogeneity and biological relevance.
Scanu, A. M., & Fless, G. M. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114625 · Cited by 573
Wang, N., Silver, D. L., Costet, P., & Tall, A. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005438200 · Cited by 570
Gotto, A. M., Whitney, E., Stein, E. A., Shapiro, D. R., Clearfield, M., Weis, S., Jou, J. Y., Langendörfer, A., Beere, P. A., Watson, D. J., et al. (2000) · Circulation · doi:10.1161/01.cir.101.5.477 · Cited by 563
Oram, J. F., Lawn, R. M., Garvin, M. R., & Wade, D. P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006738200 · Cited by 536
De Backer, G., Ambrosioni, E., Borch-Johnsen, K., Brotons, C., Cifkova, R., Dallongeville, J., Ebrahim, S., Faergeman, O., Graham, I., Mancia, G., et al. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.02.013 · Cited by 508
Sacks, F. M., Alaupovic, P., Moye, L. A., Cole, T. G., Sussex, B., Stampfer, M. J., Pfeffer, M. A., & Braunwald, E. (2000) · Circulation · doi:10.1161/01.cir.102.16.1886 · Cited by 490
ATP-binding Cassette Transporter A1 (ABCA1) Functions as a Cholesterol Efflux Regulatory Protein
Wang, N., Silver, D. L., Thiele, C., & Tall, A. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102348200 · Cited by 482
ABCA1: the gatekeeper for eliminating excess tissue cholesterol
Oram, J. F., & Lawn, R. M. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31566-2 · Cited by 480
Lamarche, B., Moorjani, S., Lupien, P. J., Cantin, B., Bernard, P.-M., Dagenais, G. R., & Despre´s, J.-P. (1996) · Circulation · doi:10.1161/01.cir.94.3.273 · Cited by 476
Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment
Sniderman, A., Furberg, C., Keech, A., van Lennep, J. R., Frohlich, J., Jungner, I., & Walldius, G. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12663-3 · Cited by 457
Self-citationNauck, M., Warnick, G. R., & Rifai, N. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.2.236 · Cited by 442
Myopathy and Rhabdomyolysis Associated With Lovastatin-Gemfibrozil Combination Therapy
Pierce, L. R. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03450010075034 · Cited by 428
Statin-induced inhibition of the Rho-signaling pathway activates PPARα and induces HDL apoA-I
Martin, G., Duez, H., Blanquart, C., Berezowski, V., Poulain, P., Fruchart, J.-C., Najib-Fruchart, J., Glineur, C., & Staels, B. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10852 · Cited by 417
Proliferation of Human Smooth Muscle Cells Promoted by Lipoprotein(a)
Grainger, D. J., Kirschenlohr, H. L., Metcalfe, J. C., Weissberg, P. L., Wade, D. P., & Lawn, R. M. (1993) · Science · doi:10.1126/science.8503012 · Cited by 408
Lipoprotein Heterogeneity and Apolipoprotein B Metabolism
Packard, C. J., & Shepherd, J. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.12.3542 · Cited by 402
Withdrawal of Cerivastatin from the World Market
Furberg, C. D., & Pitt, B. (2001) · Trials · doi:10.1186/cvm-2-5-205 · Cited by 400
Blankenhorn, D. H., Selzer, R. H., Crawford, D. W., Barth, J. D., Liu, C. R., Liu, C. H., Mack, W. J., & Alaupovic, P. (1993) · Circulation · doi:10.1161/01.cir.88.1.20 · Cited by 384
Plenge, J. K., Hernandez, T. L., Weil, K. M., Poirier, P., Grunwald, G. K., Marcovina, S. M., & Eckel, R. H. (2002) · Circulation · doi:10.1161/01.cir.0000029743.68247.31 · Cited by 354
Marcovina, S. M., Albers, J. J., Henderson, L. O., & Hannon, W. H. (1993) · Clinical Chemistry · doi:10.1093/clinchem/39.5.773 · Cited by 342
Sniderman, A. D., Scantlebury, T., & Cianflone, K. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-6-200109180-00014 · Cited by 336
Genest, J., McNamara, J. R., Ordovas, J. M., Jenner, J. L., Silberman, S. R., Anderson, K. M., Wilson, P. W. F., Salem, D. N., & Schaefer, E. J. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90520-w · Cited by 331
Hodis, H. N., Mack, W. J., Azen, S. P., Alaupovic, P., Pogoda, J. M., LaBree, L., Hemphill, L. C., Kramsch, D. M., & Blankenhorn, D. H. (1994) · Circulation · doi:10.1161/01.cir.90.1.42 · Cited by 321
Marcovina, S. M., Albers, J. J., Scanu, A. M., Kennedy, H., Giaculli, F., Berg, K., Couderc, R., Dati, F., Rifai, N., Sakurabayashi, I., et al. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.12.1956 · Cited by 313
Grundy, S. M. (2002) · Circulation · doi:10.1161/01.cir.0000038419.53000.d6 · Cited by 309
Law, M. R., Wald, N. J., Wu, T., Hackshaw, A., & Bailey, A. (1994) · BMJ · doi:10.1136/bmj.308.6925.363 · Cited by 305
Vu-Dac, N., Chopin-Delannoy, S., Gervois, P., Bonnelye, E., Martin, G., Fruchart, J.-C., Laudet, V., & Staels, B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.25713 · Cited by 297
Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism
Shachter, N. S. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200106000-00009 · Cited by 288
Thrombogenic Factors and Recurrent Coronary Events
Moss, A. J., Goldstein, R. E., Marder, V. J., Sparks, C. E., Oakes, D., Greenberg, H., Weiss, H. J., Zareba, W., Brown, M. W., Liang, C.-S., et al. (1999) · Circulation · doi:10.1161/01.cir.99.19.2517 · Cited by 280
Blankenhorn, D. H., Alaupovic, P., Wickham, E., Chin, H. P., & Azen, S. P. (1990) · Circulation · doi:10.1161/01.cir.81.2.470 · Cited by 278
Carlson, L. A., Böttiger, L. E., & åhfeldt, P. (1979) · PubMed · Cited by 270
Plasma very low density lipoproteins contain a single molecule of apolipoprotein B
Elovson, J., Chatterton, J. E., Bell, G. T., Schumaker, V. N., Reuben, M. A., Puppione, D. L., Reeve, J. R., & Young, N. L. (1988) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38425-x · Cited by 266
Rassart, E., Bedirian, A., Do Carmo, S., Guinard, O., Sirois, J., Terrisse, L., & Milne, R. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(00)00162-x · Cited by 266
Efficacy and safety of an extended-release niacin (Niaspan): a long-term study
Capuzzi, D. M., Guyton, J. R., Morgan, J. M., Goldberg, A. C., Kreisberg, R. A., Brusco, O. A., & Brody, J. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00731-0 · Cited by 254
Marcovina, S. M., Albers, J. J., Kennedy, H., Mei, J. V., Henderson, L. O., & Hannon, W. H. (1994) · Clinical Chemistry · doi:10.1093/clinchem/40.4.586 · Cited by 243
Knopp, R. H., Davidson, M., Goldberg, A. C., Kafonek, S. D., Kashyap, M., Sprecher, D., Superko, H. R., Jenkins, S., & Marcovina, S. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90284-0 · Cited by 240
Goldberg, A., Alagona, P., Capuzzi, D. M., Guyton, J., Morgan, J. M., Rodgers, J., Sachson, R., & Samuel, P. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)00703-7 · Cited by 233
Talmud, P. J., Hawe, E., Miller, G. J., & Humphries, S. E. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000035521.22199.c7 · Cited by 233
Contois, J. H., McNamara, J. R., Lammi-Keefe, C. J., Wilson, P. W., Massov, T., & Schaefer, E. J. (1996) · Clinical Chemistry · doi:10.1093/clinchem/42.4.515 · Cited by 231
Davidson, M., Ma, P., Stein, E. A., Gotto, A. M., Raza, A., Chitra, R., & Hutchinson, H. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02226-3 · Cited by 230
Carlson, L. A., Böttiger, L. E., & åhfeldt, P. (1979) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1979.tb13526.x · Cited by 229
Sniderman, A. D., St-Pierre, A. C., Cantin, B., Dagenais, G. R., Després, J.-P., & Lamarche, B. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00262-5 · Cited by 224
Handbook of lipoprotein testing
Contois, J. H. (2001) · Clinica Chimica Acta · doi:10.1016/s0009-8981(01)00486-7 · Cited by 223
Rader, D. J., Hoeg, J. M., & Brewer, H. B. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-12-199406150-00008 · Cited by 216
Sharrett, A. R., Patsch, W., Sorlie, P. D., Heiss, G., Bond, M. G., & Davis, C. E. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.7.1098 · Cited by 214
Apolipoprotein E and atherosclerosis: insight from animal and human studies
Davignon, J., Cohn, J. S., Mabile, L., & Bernier, L. (1999) · Clinica Chimica Acta · doi:10.1016/s0009-8981(99)00097-2 · Cited by 208
Guyton, J. R., Goldberg, A. C., Kreisberg, R. A., Sprecher, D. L., Superko, H. R., & O’Connor, C. M. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00448-2 · Cited by 206
Rosuvastatin: A Highly Effective New HMG‐CoA Reductase Inhibitor
Olsson, A. G., McTaggart, F., & Raza, A. (2002) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2002.tb00099.x · Cited by 204
Jin, F.-Y., Kamanna, V. S., & Kashyap, M. L. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.10.2020 · Cited by 193
Hamsten, A., Walldius, G., Szamosi, A., Dahlen, G., & de Faire, U. (1986) · Circulation · doi:10.1161/01.cir.73.6.1097 · Cited by 192
Self-citationApolipoprotein ∈4 homozygosity in young men with coronary heart disease
van Bockxmeer, F. M., & Mamotte, C. D. S. (1992) · The Lancet · doi:10.1016/0140-6736(92)93288-x · Cited by 191
Alaupovic, P., Mack, W. J., Knight-Gibson, C., & Hodis, H. N. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.4.715 · Cited by 184
Atmeh, R. F., Shepherd, J., & Packard, C. J. (1983) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(83)90172-8 · Cited by 181
Luc, G., Bard, J.-M., Ferrières, J., Evans, A., Amouyel, P., Arveiler, D., Fruchart, J.-C., & Ducimetière, P. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000022850.59845.e0 · Cited by 180
Olsson, A. G., Istad, H., Luurila, O., Ose, L., Stender, S., Tuomilehto, J., Wiklund, O., Southworth, H., Pears, J., & Wilpshaar, J. W. (2002) · American Heart Journal · doi:10.1067/mhj.2002.128049 · Cited by 177
Bittner, V., Hardison, R., Kelsey, S. F., Weiner, B. H., Jacobs, A. K., & Sopko, G. (2002) · Circulation · doi:10.1161/01.cir.0000038496.57570.06 · Cited by 168
Guyton, J. R. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.8.1177 · Cited by 167
The Relation of Apolipoproteins A-I and B in Children to Parental Myocardial Infarction
Freedman, D. S., Srinivasan, S. R., Shear, C. L., Franklin, F. A., Webber, L. S., & Berenson, G. S. (1986) · New England Journal of Medicine · doi:10.1056/nejm198609183151202 · Cited by 166
Ballantyne, C. M., Andrews, T. C., Hsia, J. A., Kramer, J. H., & Shear, C. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01638-1 · Cited by 166
Schectman, G., & Hiatt, J. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)89459-4 · Cited by 164
Apolipoprotein A-II, HDL metabolism and atherosclerosis
Tailleux, A., Duriez, P., Fruchart, J., & Barthelemy-Clavey, V. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00751-1 · Cited by 163
Hurt-Camejo, E., Camejo, G., Rosengren, B., Lopez, F., Wiklund, O., & Bondjers, G. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42610-0 · Cited by 162
Apolipoprotein Concentrations During Treatment and Recurrent Coronary Artery Disease Events
van Lennep, J. E. R., Westerveld, H. T., van Lennep, H. W. O. R., Zwinderman, A. H., Erkelens, D. W., & van der Wall, E. E. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.11.2408 · Cited by 160
Ruotolo, G., Ericsson, C.-G., Tettamanti, C., Karpe, F., Grip, L., Svane, B., Nilsson, J., de Faire, U., & Hamsten, A. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00442-2 · Cited by 158
Jungner, I., Marcovina, S. M., Walldius, G., Holme, I., Kolar, W., & Steiner, E. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.8.1641 · Cited by 158
Self-citationBrewer, H. B. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00308-2 · Cited by 158
Brown, W. V., Bays, H. E., Hassman, D. R., McKenney, J. M., Chitra, R., Hutchinson, H. G., & Miller, E. (2002) · American Heart Journal · doi:10.1067/mhj.2002.129312 · Cited by 156
Fibrates and statins in the treatment of hyperlipidaemia: an appraisal of their efficacy and safety
Shepherd, J. (1995) · European Heart Journal · doi:10.1093/eurheartj/16.1.5 · Cited by 155
Bachorik, P. S., Lovejoy, K. L., Carroll, M. D., & Johnson, C. L. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.12.2364 · Cited by 155
Bays, H. E., Dujovne, C. A., McGovern, M. E., White, T. E., Kashyap, M. L., Hutcheson, A. G., & Crouse, J. R. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00007-9 · Cited by 154
Apolipoprotein E4: an allele associated with many diseases
Smith, J. D. (2000) · Annals of Medicine · doi:10.3109/07853890009011761 · Cited by 146
Durrington, P. N., Mackness, M., Bhatnagar, D., Julier, K., Prais, H., Arrol, S., Morgan, J., & Wood, G. N. I. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00003-3 · Cited by 145
Blasetto, J. W., Stein, E. A., Brown, W. V., Chitra, R., & Raza, A. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00003-1 · Cited by 144
The Friedewald Formula Underestimates LDL Cholesterol at low Concentrations
Scharnagl, H., Nauck, M. A., Wieland, H., & März, W. (2001) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2001.068 · Cited by 141
Schneck, D. W., Knopp, R. H., Ballantyne, C. M., McPherson, R., Chitra, R., & Simonson, S. G. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02994-6 · Cited by 140
Jin, F.-Y., Kamanna, V. S., & Kashyap, M. L. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.4.1051 · Cited by 138
Chan, D. C., Watts, G. F., Redgrave, T. G., Mori, T. A., & Barrett, P. H. R. (2002) · Metabolism · doi:10.1053/meta.2002.33339 · Cited by 137
Lipoprotein[a] as a risk factor for preclinical atherosclerosis.
Schreiner, P. J., Morrisett, J. D., Sharrett, A. R., Patsch, W., Tyroler, H. A., Wu, K., & HEISS, G. M. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.6.826 · Cited by 132
Paoletti, R., Fahmy, M. I., Mahla, G., Mizan, J., & Southworth, H. (2001) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182670100800608 · Cited by 130
Avogaro, P., Bon, G. B., Cazzolato, G., & Rorai, E. (1980) · Atherosclerosis · doi:10.1016/0021-9150(80)90094-5 · Cited by 125
Regulation of apo A-I gene expression by fibrates
Staels, B., & Auwerx, J. H. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00313-4 · Cited by 124
Crouse, J. R., Frohlich, J. J., Ose, L., Mercuri, M. F., & Tobert, J. A. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00153-8 · Cited by 124
Sakai, T., Kamanna, V. S., & Kashyap, M. L. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq1001.096624 · Cited by 123
Beyond LDL Cholesterol Reduction
Superko, H. R. (1996) · Circulation · doi:10.1161/01.cir.94.10.2351 · Cited by 117
Pleiotropic effects of statins and their clinical significance
LaRosa, J. C. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01643-5 · Cited by 104
Triglycerides and small dense LDL: the twin Achilles heels of the Friedewald formula
Sniderman, A. D., Blank, D., Zakarian, R., Bergeron, J., & Frohlich, J. (2003) · Clinical Biochemistry · doi:10.1016/s0009-9120(03)00117-6 · Cited by 100
Mechanisms of high density lipoprotein-mediated efflux of cholesterol from cell plasma membranes
Phillips, M. C., Gillotte, K. L., Haynes, M. P., Johnson, W. J., Lund‐Katz, S., & Rothblat, G. H. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00312-2 · Cited by 98
Arad, Y., Ramakrishnan, R., & Ginsberg, H. N. (1992) · Metabolism · doi:10.1016/0026-0495(92)90206-p · Cited by 91
Variations in apolipoproteins B and A, during the course of myocardial infarction
Avogaro, P., Bon, G. B., Cazzolato, G., Quinci, G. B., Sanson, A. J., SPARLA, M., Zagatti, G., & Caturelli, G. (1978) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1978.tb00824.x · Cited by 87
Rader, D. J., Davidson, M. H., Caplan, R. J., & Pears, J. S. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00005-5 · Cited by 84
Effect of fenofibrate on brachial artery flow-mediated dilatation in type 2 diabetes mellitus
Playford, D. A., Watts, G. F., Best, J. D., & Burke, V. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02847-3 · Cited by 80
Jungner, I., Walldius, G., Holme, I., Kolar, W., & Steiner, E. (1992) · International Journal of Clinical & Laboratory Research · doi:10.1007/bf02591655 · Cited by 80
Self-citationCuomo, S. (2002) · European Heart Journal · doi:10.1053/euhj.2001.3111 · Cited by 80
Hypertension, vascular disease, and prevention
(2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)80004-8 · Cited by 79
High density lipoprotein, apolipoprotein A-1, and coronary artery disease
Srivastava, R., & Srivastava, N. (2000) · Molecular and Cellular Biochemistry · doi:10.1023/a:1007111830472 · Cited by 74
Current, New and Future Treatments in Dyslipidaemia and Atherosclerosis
Chong, P. H., & Bachenheimer, B. S. (2000) · Drugs · doi:10.2165/00003495-200060010-00005 · Cited by 72
The Role of Lipoprotein A-I and Lipoprotein A-I/A-II in Predicting Coronary Artery Disease
O’Brien, T., Nguyen, T. T., Hallaway, B. J., Hodge, D. O., Bailey, K. R., Holmes, D. R., & Kottke, B. A. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.2.228 · Cited by 69
Alaupovic, P. (1981) · Canadian Journal of Biochemistry · doi:10.1139/o81-079 · Cited by 69
Role of lipid and lipoprotein profiles in risk assessment and therapy
Ballantyne, C. M., & Hoogeveen, R. C. (2003) · American Heart Journal · doi:10.1016/s0002-8703(02)94701-0 · Cited by 68
Coronary artery disease in patients at low risk — apolipoprotein AI as an independent risk factor
Francis, M. C., & Frohlich, J. J. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00528-1 · Cited by 67
Apolipoprotein E Polymorphisms and Concentration in Chronic Diseases and Drug Responses
Siest, G., Bertrand, P., Herbeth, B., Vincent‐Viry, M., Schiele, F., Sass, C., & Visvikis‐Siest, S. (2000) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2000.122 · Cited by 67
Ginsburg, G. S., Safran, C., & Pasternak, R. C. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90742-4 · Cited by 67
Westerveld, H. T., van Lennep, J. E. R., van Lennep, H. W. O. R., Liem, A. H., de Boo, J. A. J., van der Schouw, Y. T., & Erkelens, D. W. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.7.1101 · Cited by 65
How, when, and why to use apolipoprotein B in clinical practice
Sniderman, A. D. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02633-4 · Cited by 65
Comparison of efficacy and safety of atorvastatin (10 mg) with simvastatin (10 mg) at six weeks
Insull, W., Kafonek, S. D., Goldner, D., & Zieve, F. J. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01430-2 · Cited by 62
Eriksson, M., Hådell, K., Holme, I., Walldius, G., & Kjellström, T. (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00294.x · Cited by 61
Self-citationHigh-density lipoprotein subclasses and apolipoprotein A-I
Duriez, P., & Fruchart, J. (1999) · Clinica Chimica Acta · doi:10.1016/s0009-8981(99)00096-0 · Cited by 61
Wilcox, L. J., Barrett, P. H. R., & Huff, M. W. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33512-4 · Cited by 60
Keulen, E. T. P., Kruijshoop, M., Schaper, N. C., Hoeks, A. P. G., & de Bruin, T. W. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0202.104100 · Cited by 59
(1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00677-7 · Cited by 57
Assmann, G. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01448-5 · Cited by 57
Cardiac and vascular structure and function are related to lipid peroxidation and metabolism
Steer, P., Millgård, J., Sarabi, D. M., Basu, S., Vessby, B. O., Kahan, T., Edner, M., & Lind, L. (2002) · Lipids · doi:10.1007/s11745-002-0885-3 · Cited by 56
Short-term Prognostic Value of Lipid Measurements in Patients with Angina pectoris
Bolíbar, I., Assmann, G., Thompson, S. G., von Eckardstein, A., & The ECAT Angina Pectoris Study Group (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614155 · Cited by 55
Walldius, G., Jungner, I., Kolar, W., Holme, I., & Steiner, E. (1992) · PubMed · Cited by 54
Self-citationAssociations between change in C-reactive protein and serum lipids during statin treatment
Strandberg, T. E., Vanbanen, H., & Tikkanen, M. J. (2000) · Annals of Medicine · doi:10.3109/07853890008998838 · Cited by 52
Battula, S., Fitzsimons, O., Moreno, S., Owens, D., Collins, P. B., Johnson, A., & TOMKIN, G. H. (2000) · Metabolism · doi:10.1053/meta.2000.7744 · Cited by 49
Connelly, P. W., Poapst, M. E., Davignon, J., Lussier‐Cacan, S., Reeder, B. A., Lessard, R., Hegele, R. A., & Csima, A. (1999) · PubMed · Cited by 48
Miremadi, S., Sniderman, A. D., & Frohlich, J. J. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.3.484 · Cited by 48
Garfagnini, A., Devoto, G., Rosselli, P., Boggiano, P., & VENTURINI, M. (1995) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060937 · Cited by 47
Bard, J., Charles, M.-A. A., Juhan-Vague, I., Vague, P., André, P., Safar, M. E., Fruchart, J., & Eschwège, É. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.3.407 · Cited by 46
Després, J., Lemieux, I., Salomon, H., & Delaval, D. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.00988.x · Cited by 44
Regulation of apolipoprotein E production in macrophages (review).
Larkin, L., Khachigian, L. M., & Jessup, W. (2000) · International Journal of Molecular Medicine · doi:10.3892/ijmm.6.3.253 · Cited by 37
Lundstam, U., Herlitz, J. D., Karlsson, T., et al. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.00937.x · Cited by 37
Berglund, L., Witztum, J. L., Galeano, N. F., Khouw, A., Ginsberg, H. N., & Ramakrishnan, R. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32577-3 · Cited by 36
Durrington, P. N. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.3.401 · Cited by 30
Scanu, A. M. (2001) · Current Cardiology Reports · doi:10.1007/s11886-001-0055-4 · Cited by 28
Insights into apolipoprotein C metabolism from transgenic and gene-targeted mice.
Jong, M., & Havekes, L. M. (2000) · PubMed · Cited by 26
Steer, P., Hulthe, J., Millgård, J., Sarabi, D. M., Basu, S., Vessby, B. O., & Lind, L. (2002) · Lipids · doi:10.1007/s11745-002-1010-3 · Cited by 22
Apolipoproteins: the new prognostic indicator?
PACKARD, C. (2003) · European Heart Journal Supplements · doi:10.1016/s1520-765x(03)90032-0 · Cited by 19
Otvos, J. D. (2002) · Journal of Laboratory Medicine · doi:10.1515/labmed.2002.059 · Cited by 14
Fibrates and coronary heart disease reduction in diabetes
Robins, S. J. (2002) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200208000-00004 · Cited by 11
Snehalatha, C., Ramachandran, A., Sivasankari, S., Satyavani, K., Viswanathan, V., Misra, J., Girinath, M. R., & Sathyamurthy, I. (2002) · PubMed · Cited by 10
In Vivo Metabolism of HDL, Apo A-I, and Lp A-I, and Function of HDL -A Clinical Perspective
Zhang, B., Saku, K., & Ohta, T. (2000) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat1994.7.59 · Cited by 8
Vogel, R. A. (1998) · Clinical cornerstone · doi:10.1016/s1098-3597(98)90006-0 · Cited by 8
Statins: Monotherapy or Combination Strategy for the Treatment of Dyslipidemia
Carmena, R. (2002) · Heart Drug · doi:10.1159/000065942 · Cited by 3
Apolipoprotein B metabolism in dyslipidaemia and the effect of drugs.
Cj, P. (1999) · PubMed · Cited by 3
Cited by
Yeh, F. L., Wang, Y., Tom, I., Gonzalez, L. C., & Sheng, M. (2016) · Neuron · doi:10.1016/j.neuron.2016.06.015 · Cited by 943
Langsted, A., Freiberg, J. J., & Nordestgaard, B. G. (2008) · Circulation · doi:10.1161/circulationaha.108.804146 · Cited by 588
WALLDIUS, G., & JUNGNER, I. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01643.x · Cited by 583
Self-citationBiological and Nutritional Properties of Palm Oil and Palmitic Acid: Effects on Health
Mancini, A., Imperlini, E., Nigro, E., Montagnese, C., Daniele, A., Orrù, S., & Buono, P. (2015) · Molecules · doi:10.3390/molecules200917339 · Cited by 557
OLOFSSON, S. ‐., & BORÈN, J. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01556.x · Cited by 330
Metadata
- Authors
- Walldius, G., & Jungner, I.
- Venue
- Journal of Internal Medicine
- Publisher
- Wiley
- Published
- 2004-01-26
- Volume
- 255
- Issue
- 2
- Pages
- 188-205
- ISSN
- 0954-6820 (ISSN-L)
- 1365-2796
- OpenAlex
- W1967312649
- Cited by
- 396
- References
- 152
- FWCI
- 22.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.